PolyNovo Limited (CALZF)

Market Cap	516.91M
Revenue (ttm)	71.53M
Net Income (ttm)	3.65M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	141.45
Forward PE	77.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	1,001
Open	0.7387
Previous Close	0.7990
Day's Range	0.7387 - 0.7990
52-Week Range	0.6145 - 1.8200
Beta	1.56
RSI	49.54
Earnings Date	Aug 22, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 254
• Stock Exchange: OTCMKTS
• Ticker Symbol: CALZF

Financial Performance

Financial numbers in AUD